Antiviral Cationic Peptides as a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide-Reference-Cited by-同舟云学术

Antiviral Cationic Peptides as a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide

Published:2013-11 Issue:11 Volume:17 Page:560-567
ISSN:1536-2310
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

Rothan Hussin A.¹,Mohamed Zulqarnain²,Suhaeb Abdulrazzaq M.³,Rahman Noorsaadah Abd⁴,Yusof Rohana¹

Affiliation:

1. Department of Molecular Medicine, University of Malaya, Kuala Lumpur, Malaysia.

2. Department of Genetics, Institute of Biological Science, University of Malaya, Kuala Lumpur, Malaysia.

3. University Hospital, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

4. Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/omi.2013.0056

Reference35 articles.

1. Novel approaches to flavivirus drug discovery

2. Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics

3. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

4. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases

5. Focus on flaviviruses: current and future drug targets

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease;Computational Biology and Chemistry;2024-02

2. Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic;Journal of Peptide Science;2023-07-28

3. Antiviral Peptides in Antimicrobial Surface Coatings—From Current Techniques to Potential Applications;Viruses;2023-02-27

4. Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy;Virus Research;2023-01

5. Antiviral peptides against dengue virus;Viral Infections and Antiviral Therapies;2023